Metalloproteinases in juvenile angiofibroma-a collagen rich tumor

Human Pathology

Volumn 39, Issue 2, 2008, Pages 259-268

  Duerr, Stephan ^a   Wendler, Olaf ^a   Aigner, Thomas ^b   Karosi, Stefanie ^a   Schick, Bernhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Juvenile angiofibroma; Mast cells; Metalloproteinase

Indexed keywords

COLLAGEN; COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; NASOPHARYNX FIBROMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TURBINATE; WESTERN BLOTTING; ZYMOGRAPHY;

ADOLESCENT; ADULT; ANGIOFIBROMA; COLLAGEN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; METALLOPROTEASES; NOSE NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR MARKERS, BIOLOGICAL; TURBINATES;

EID: 38149107402     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.06.015     Document Type: Article

References (37)

1. Schick B., and Kahle G. Radiological findings in angiofibroma. Acta Radiol 41 (2000) 585-593
2. Abraham S.C., Montgomery E.A., Giardiello F.M., and Wu T.T. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 158 (2001) 1073-1078
3. Schick B., Rippel C., Brunner C., Jung V., Plinkert P.K., and Urbschat S. Numerical sex chromosome aberrations in juvenile angiofibromas: genetic evidence for an androgen-dependent tumor?. Oncol Rep 10 (2003) 1251-1255
4. Schick B., and Urbschat S. New aspects of pathogenesis of juvenile angiofibromas. Hosp Med 65 (2004) 269-273
5. Hwang H.C., Mills S.E., Patterson K., and Gown A.M. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 11 (1998) 1122-1126
6. Schick B., Wemmert S., Jung V., Steudel W.I., Montenarh M., and Urbschat S. Genetic heterogeneity of the MYC oncogene in advanced juvenile angiofibromas. Cancer Genet Cytogenet 164 (2006) 25-31
7. Amir A.L., Barua M., McKnight N.C., Cheng S., Yuan X., and Balk S.P. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278 (2003) 30828-30834
8. Schick B., Wemmert S., Bechtel U., et al. Comprehensive genomic analysis identifies MDM2 and AURKA as novel amplified genes in juvenile angiofibromas. Head & Neck 29 (2007) 479-487
9. Schick B., Veldung B., Wemmert S., et al. p53 and Her-2/neu in juvenile angiofibromas. Oncol Rep 13 (2005) 453-457
10. Yoon S.O., Park S.J., Yun C.H., and Chung A.S. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 36 (2003) 128-137
11. Handsley M.M., and Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115 (2005) 849-860
12. Andrews J.C., Fisch U., Valavanis A., Aeppli U., and Makek M.S. The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach. Laryngoscope 99 (1989) 429-437
13. McKenna L.A., Gehrsitz A., Soeder S., Eger W., Kirchner T., and Aigner T. Effective isolation of high quality total RNA from human adult articular cartilage. Anal Biochem 286 (2000) 80-85
14. Bau B., Gebhard P.M., Haag J., Knorr T., Bartnik E., and Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46 (2002) 2648-2657
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
16. Wendler O., Schäfer R., and Schick B. Mast cells and T-lymphocytes in juvenile angiofibromas. Eur Arch Otorhinolaryngol 264 (2007) 769-775
17. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (2002) 161-174
18. Golubkov V.S., and Strongin A.Y. Proteolysis-driven oncogenesis. Cell Cycle 6 (2007) 147-150
19. Schick B., Wemmert S., Bechtel U., et al. Comprehensive genomic analysis identifies MDM2 and AURKA as novel amplified genes in juvenile angiofibromas. Head Neck 29 (2007) 479-487
20. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21 (2001) 1104-1117
21. Oh J., Takahashi R., Adachi E., et al. Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 5 (2004) 5041-5048
22. Chantrain C.F., Shimada H., Jodele S., et al. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 64 (2004) 1675-1686
23. Vince G.H., Wagner S., Pietsch T., et al. Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas. Int J Dev Neurosci 17 (1999) 437-445
24. Xu J., Rodriguez D., Petitclerc E., et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154 (2001) 1069-1079
25. Brieger J., Wierzbicka M., Sokolo M., Roth Y., Szyfter W., and Mann W.J. Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile angiofibromas. Arch Otolaryngol Head Neck Surg 130 (2004) 727-731
26. Dillard D.G., Cohen C., Muller S., et al. Immunolocalization of activated transforming growth factor beta 1 in juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 126 (2000) 723-725
27. Patterson B.C., and Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272 (1997) 28823-28825
28. Davis G.E., Pintar Allen K.A., Salazar R., and Maxwell S.A. Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. J Cell Sci 114 (2001) 917-930
29. Girolamo N.D., Indoh I., Jackson N., et al. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J Immunol 177 (2006) 2638-2650
30. Fang K.C., Raymond W.W., Lazarus S.C., and Caughey G.H. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest 97 (1996) 1589-1596
31. Lohi J., Harvima I., and Keski-Oja J. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. Cell Biochem 50 (1992) 337-349
32. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., and Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280 (2005) 9291-9296
33. Edwards S.T., Cruz A.C., Donnelly S., et al. C-kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases. J Pathol 206 (2005) 279-290
34. Björklund M., and Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755 (2005) 37-69
35. Seftor R.E., Seftor E.A., De Larco J.E., et al. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis 16 (1998) 217-225
36. Sorsa T., Ramamurthy N.S., Vernillo A.T., et al. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases. J Rheumatol 25 (1998) 975-982
37. Teronen O., Heikkila P., Konttinen Y.T., et al. MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci 878 (1999) 453-465